Related Experiment Video
Updated: Aug 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
HIF-1alpha and p53 as targets of NO in affecting cell proliferation, death and adaptation
Jie Zhou1, Tobias Schmid, Bernhard Brüne
1Department of Cell Biology, Faculty of Biology, University of Kaiserslautern, Kaiserslautern, Germany.
Abstract:
During the past years nitric oxide (NO) signaling became an integral component in understanding physiological and pathophysiological processes of cell proliferation, death or cellular adaptation. Among other activities NO affects multiple targets that allow regulation of gene expression. Although there is no evidence for direct NO-responsive DNA elements within promotor regions of eukaryotic genes numerous indirect signaling pathways exist to explain NO-regulated gene expression. A characteristic feature of some transcription factors such as hypoxia inducible factor-1alpha (HIF-1alpha) or p53 (tumor suppressor p53) is their low protein abundance in unstressed cells due to efficient 26S proteasomal degradation of the protein. Characteristically, the protein amount of HIF-1alpha or p53 is increased steeply upon hypoxic stress or mechanisms that require activation of "guardian of the genome", i.e. p53. Current available data illustrate that NO is endowed with the ability to mimic a hypoxic response by stabilizing HIF-1alpha and/or to accumulate p53 and thus to affect viability decisions. Here we review recent advances in understanding molecular mechanisms how NO affects stability regulation of HIF-1alpha and p53. Moreover, we summarize existing concepts how HIF-1alpha and p53 interact to direct proliferation, death or adaptation. Considering HIF-1alpha and p53 as targets of reactive nitrogen intermediates (RNI) may provide insights into basic chemical reactions, biochemical signal transduction pathways with broad implications for medicine.
Insights
Nitric oxide (NO) stabilizes hypoxia-inducible factor-1alpha (HIF-1alpha) and tumor suppressor p53, mimicking hypoxic responses. This NO signaling influences cell fate decisions, impacting proliferation, death, and adaptation.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- Nitric oxide (NO) is a key signaling molecule in physiological and pathophysiological processes.
- NO regulates gene expression indirectly through various signaling pathways, not via direct DNA elements.
- Key transcription factors like hypoxia-inducible factor-1alpha (HIF-1alpha) and p53 are regulated by protein stability.
Purpose of the Study:
- To review recent advances in understanding how NO affects the stability of HIF-1alpha and p53.
- To summarize how HIF-1alpha and p53 interact to regulate cell proliferation, death, and adaptation.
- To explore the implications of NO targeting HIF-1alpha and p53 in medicine.
Main Methods:
- Literature review of recent advances in NO signaling research.
- Analysis of molecular mechanisms regulating HIF-1alpha and p53 stability.
- Synthesis of existing concepts on HIF-1alpha and p53 interactions.
Main Results:
- NO can mimic hypoxic responses by stabilizing HIF-1alpha.
- NO can lead to the accumulation of p53.
- NO-mediated stabilization of HIF-1alpha and p53 influences cell viability decisions.
Conclusions:
- NO signaling plays a critical role in regulating cell fate through HIF-1alpha and p53.
- Understanding NO's effect on these transcription factors provides insights into basic chemical reactions and signal transduction.
- Targeting HIF-1alpha and p53 by reactive nitrogen intermediates has broad medical implications.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity

